FIGURE 7.
Pirfenidone level in the heart, liver, spleen, lung and kidney of rats with pulmonary fibrosis after administration to the pulmonary system (4 mgkg−1) (n = 3) (**p < 0.01).
Pirfenidone level in the heart, liver, spleen, lung and kidney of rats with pulmonary fibrosis after administration to the pulmonary system (4 mgkg−1) (n = 3) (**p < 0.01).